A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease

NCT01388933 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

79

Enrollment

INDUSTRY

Sponsor class

Stopped Study stopped due to low enrollment

Conditions

Crohn's Disease

Interventions

DRUG: TU-100
DRUG: Matching Placebo

Sponsor

Tsumura USA

Collaborators

[object Object]